| Association of obesity with adverse long-term outcomes in hypertrophic cardiomyopathy C Fumagalli, N Maurizi, SM Day, EA Ashley, M Michels, SD Colan, ... JAMA cardiology 5 (1), 65-72, 2020 | 110 | 2020 |
| Clinical risk score to predict in-hospital mortality in COVID-19 patients: a retrospective cohort study C Fumagalli, R Rozzini, M Vannini, F Coccia, G Cesaroni, F Mazzeo, ... BMJ open 10 (9), e040729, 2020 | 81 | 2020 |
| Factors associated with persistence of symptoms 1 year after COVID-19: A longitudinal, prospective phone-based interview follow-up cohort study C Fumagalli, C Zocchi, L Tassetti, MV Silverii, C Amato, L Livi, ... European Journal of Internal Medicine 97, 36-41, 2022 | 78* | 2022 |
| Prevalence of cardiac amyloidosis among adult patients referred to tertiary centres with an initial diagnosis of hypertrophic cardiomyopathy N Maurizi, V Rella, C Fumagalli, S Salerno, S Castelletti, F Dagradi, ... International Journal of Cardiology 300, 191-195, 2020 | 75 | 2020 |
| β-blockers: Their new life from hypertension to cancer and migraine C Fumagalli, N Maurizi, N Marchionni, D Fornasari Pharmacological research 151, 104587, 2020 | 70 | 2020 |
| Prevalence of subcutaneous implantable cardioverter-defibrillator candidacy based on template ECG screening in patients with hypertrophic cardiomyopathy I Olivotto, LRAO Nordkamp, K Baldini, C Fumagalli, TF Brouwer, ... Heart rhythm 13 (2), 457-463, 2016 | 59 | 2016 |
| Temporal trend of age at diagnosis in hypertrophic cardiomyopathy: an analysis of the international sarcomeric human cardiomyopathy registry M Canepa, C Fumagalli, G Tini, J Vincent-Tompkins, SM Day, EA Ashley, ... Circulation: Heart Failure 13 (9), e007230, 2020 | 54 | 2020 |
| Selection and application of tissue microRNAs for nonendoscopic diagnosis of Barrett’s esophagus X Li, S Kleeman, SB Coburn, C Fumagalli, J Perner, S Jammula, ... Gastroenterology 155 (3), 771-783. e3, 2018 | 42 | 2018 |
| Incidence and risk factors for pacemaker implantation in light‐chain and transthyretin cardiac amyloidosis A Porcari, M Rossi, F Cappelli, M Canepa, B Musumeci, A Cipriani, G Tini, ... European Journal of Heart Failure 24 (7), 1227-1236, 2022 | 40 | 2022 |
| The effect of leadership on hand hygiene: assessing hand hygiene adherence prior to patient contact in 2 infectious disease units in Tuscany SR Lieber, E Mantengoli, S Saint, KE Fowler, C Fumagalli, D Bartolozzi, ... Infection Control & Hospital Epidemiology 35 (03), 313-316, 2014 | 37 | 2014 |
| SGLT-2 inhibitors and in-stent restenosis-related events after acute myocardial infarction: an observational study in patients with type 2 diabetes R Marfella, C Sardu, N D’Onofrio, C Fumagalli, L Scisciola, FC Sasso, ... BMC medicine 21 (1), 71, 2023 | 35 | 2023 |
| Low QRS voltages in cardiac amyloidosis: clinical correlates and prognostic value A Cipriani, L De Michieli, A Porcari, L Licchelli, G Sinigiani, G Tini, ... Cardio Oncology 4 (4), 458-470, 2022 | 35 | 2022 |
| Frailty, sarcopenia and cachexia in heart failure patients: different clinical entities of the same painting M Beltrami, C Fumagalli, M Milli World Journal of Cardiology 13 (1), 1, 2021 | 26 | 2021 |
| Sex-related differences in exercise performance and outcome of patients with hypertrophic cardiomyopathy L Ghiselli, A Marchi, C Fumagalli, N Maurizi, A Oddo, F Pieri, F Girolami, ... European Journal of Preventive Cardiology 27 (17), 1821-1831, 2020 | 26 | 2020 |
| Ocular hypertension and glaucoma following vitrectomy: a systematic review A Miele, A Govetto, C Fumagalli, S Donati, I Biagini, C Azzolini, S Rizzo, ... Retina 38 (5), 883-890, 2018 | 26 | 2018 |
| Changes in the perceived epidemiology of amyloidosis: 20 year-experience from a Tertiary Referral Centre in Tuscany M Zampieri, G Nardi, G Del Monaco, M Allinovi, M Gabriele, C Zocchi, ... International Journal of Cardiology 335, 123-127, 2021 | 25 | 2021 |
| Predicting mortality risk in older hospitalized persons with COVID-19: a comparison of the COVID-19 mortality risk score with frailty and disability C Fumagalli, A Ungar, R Rozzini, M Vannini, F Coccia, G Cesaroni, ... Journal of the American Medical Directors Association 22 (8), 1588-1592. e1, 2021 | 24 | 2021 |
| Timing of invasive septal reduction therapies and outcome of patients with obstructive hypertrophic cardiomyopathy L Cavigli, C Fumagalli, N Maurizi, A Rossi, A Arretini, M Targetti, ... International Journal of Cardiology 273, 155-161, 2018 | 23 | 2018 |
| Prevalence, causes and predictors of cardiovascular hospitalization in patients with hypertrophic cardiomyopathy M Ciabatti, C Fumagalli, M Beltrami, E Vignini, L Martinese, A Tomberli, ... International journal of cardiology 318, 94-100, 2020 | 21 | 2020 |
| Sex-related differences in clinical presentation and all-cause mortality in patients with cardiac transthyretin amyloidosis and light chain amyloidosis M Zampieri, A Argiro, M Allinovi, L Tassetti, C Zocchi, M Gabriele, ... International Journal of Cardiology 351, 71-77, 2022 | 16 | 2022 |
